DCIS-like tumoroid can reduce adipocyte differentiation (PPAR-γ, AP2), decrease tumor-suppressor adipokine (adiponectin), and increase both adipocyte lipolysis (HSL) and tumor-enhancer adipokine (leptin) gene expression. Here, LEP is linked to ductal breast carcinoma in situ.